原发性血小板增多症相关的急性心肌梗死1例

林旭; 王琳; 刘元; 田雨; 张尉华

doi:10.16766/j.cnki.issn.1674-4152.002438

原发性血小板增多症相关的急性心肌梗死1例

doi: 10.16766/j.cnki.issn.1674-4152.002438

吉林大学第一医院心血管内科，吉林长春 130021

详细信息

通讯作者:
张尉华，E-mail：weihua@jlu.edu.cn

中图分类号: R558.3 R542.22
计量
- 文章访问数: 125
- HTML全文浏览量: 94
- PDF下载量: 10
- 被引次数: 0
出版历程
- 收稿日期: 2021-03-11
- 网络出版日期: 2022-08-20

摘要

- 原发性血小板增多症 /
- 急性心肌梗死 /
- 血栓形成

HTML全文

图 1 2020年3月26日患者冠状动脉造影术前心电图

注：Ⅰ、aVL、V1~V5导联ST段抬高0.1~0.3 mV。

Figure 1. The patient ' s electrocardiogram before coronary angiography on March 26, 2020

下载: 全尺寸图片幻灯片

图 2 患者肺CT影像

注：提示肺水肿。

Figure 2. CT image of the patient ' s lungs

下载: 全尺寸图片幻灯片

图 3 冠状动脉造影术中患者冠脉情况

注：冠脉造影提示LM近段闭塞。

Figure 3. Coronary condition of patients during coronary angiography

下载: 全尺寸图片幻灯片

图 4 患者PCI术后冠状动脉造影结果

注：于LM-LAD植入支架后，LAD血流恢复。

Figure 4. Coronary angiography results of patients after PCI

下载: 全尺寸图片幻灯片

参考文献(16)

[1]	POSFAI E, MARTON I, BORBENYI Z, et al. Myocardial infarction as a thrombotic complication of essential thrombocythemia and polycythemia vera[J]. Anatol J Cardiol, 2016, 16(6): 397-402.
[2]	LUBBERICH R K, WALENDA T, GOECKE T W, et al. Serum of myeloproliferative neoplasms stimulates hematopoietic stem and progenitor cells[J]. PLoS One, 2018, 13(5): 1-12.
[3]	王晓培, 程家凤, 郑茜茜. JAK2V617F突变阳性骨髓增殖性肿瘤患者凝血功能异常及伴发血管性疾病的临床分析[J]. 河北医药, 2016, 38(11): 1617-1620. https://www.cnki.com.cn/Article/CJFDTOTAL-HBYZ201611005.htm WANG X P, CHENG J F, ZHENG Q Q. Analysis for the coagulation disorder and complicated vascular diseases in patients with JAK2V617F mutation-positive myeloproliferative neoplasms[J]. Hebei Medical Journal, 2016, 38(11): 1617-1620. https://www.cnki.com.cn/Article/CJFDTOTAL-HBYZ201611005.htm
[4]	MURATA M, SUZUKI R, NISHIDA T, et al. Allogeneic hematopoietic stem cell transplantation for post-essential thrombocythemia and post-polycythemia vera myelofibrosis[J]. Intern Med, 2020, 59(16): 1947-1956. doi: 10.2169/internalmedicine.4375-19
[5]	HONG J, LEE J H, BYUN J M, et al. Risk of disease transformation and second primary solid tumors in patients with myeloproliferative neoplasms[J]. Blood Adv, 2019, 3(22): 3700-3708. doi: 10.1182/bloodadvances.2019000655
[6]	GALVEZ C, STEIN B L. Thrombocytosis and thrombosis: Is there really a correlation?[J]. Curr Hematol Malig Rep, 2020, 15(4): 261-267. doi: 10.1007/s11899-020-00588-z
[7]	PRAJS I, KULICZKOWSKI K. Predictive factors of thrombosis for patients with essential thrombocythaemia: A single center study[J]. Adv Clin Exp Med, 2017, 26(1): 115-121. doi: 10.17219/acem/68578
[8]	JUTZI J S, MULLALLY A. Remodeling the bone marrow microenvironment-a proposal for targeting pro-inflammatory contributors in MPN[J]. Front Immunol, 2020, 11(2): 1-8.
[9]	杨旭, 孙慧, 邓丽, 等. 原发性血小板增多症合并心肌梗死10例[J]. 中国循环杂志, 2016, 31(2): 119-121. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGXH201602005.htm YANG X, SUN H, DENG L, et al. Analysis of essential thrombocythemia combining myocardial infarction in 10 patients[J]. Chinese Circulation Journal, 2016, 31(2): 119-121. https://www.cnki.com.cn/Article/CJFDTOTAL-ZGXH201602005.htm
[10]	KHAHESHI I, MEMARYAN M, TAHERKHANI M, et al. Acute ST-segment elevation myocardial infarction as the first manifestation of essential thrombocytosis successfully treated with thrombectomy alone[J]. Cardiovasc Interv Ther, 2016, 31(4): 275-278. doi: 10.1007/s12928-015-0347-z
[11]	中华医学会血液学分会白血病淋巴瘤学组. 原发性血小板增多症诊断与治疗中国专家共识(2016年版)[J]. 中华血液学杂志, 2016, 37(10): 833-836. doi: 10.3760/cma.j.issn.0253-2727.2016.10.001 Leukemia and Lymphoma Group, Chinese Society of He. Chinese expert consensus on the diagnosis and treatment of essential thrombcythaemia (2016)[J]. Chinese Journal of Hematology, 2016, 37(10): 833-836. doi: 10.3760/cma.j.issn.0253-2727.2016.10.001
[12]	TEFFERI A, BARBUI T. Polycythemia vera and essential thrombocythemia: 2019 update on diagnosis, risk-stratification and management[J]. Am J Hematol, 2019, 94(1): 133-143. doi: 10.1002/ajh.25303
[13]	江燕, 杨思进, 白雪, 等. 原发性血小板增多症导致急性心肌梗死1例治疗体会[J]. 临床心血管杂志, 2016, 32(1): 105-107. https://www.cnki.com.cn/Article/CJFDTOTAL-LCXB201601029.htm JIANG Y, YANG S J, BAI X, et al. Medical treatment experience of acute myocardial infarction resulted from primary thrombocytosis[J]. Journal of Clinical Cardiology, 2016, 32(1): 105-107. https://www.cnki.com.cn/Article/CJFDTOTAL-LCXB201601029.htm
[14]	ABUTINEH M, YASSIN M A. Extreme levels of platelet count in essential thrombocythemia: Management and outcome, report of two cases[J]. Case Rep Oncol, 2020, 13(2): 606-610. doi: 10.1159/000507363
[15]	FRANCHINI M, MANNUCCI P M. Acquired von Willebrand syndrome: Focused for hematologists[J]. Haematologica, 2020, 105(8): 2032-2037.
[16]	ROTTENSTREICH A, KLEINSTERN G, KRICHEVSKY S, et al. Factors related to the development of acquired von Willebrand syndrome in patients with essential thrombocythemia and polycythemia vera[J]. Eur J Intern Med, 2017, 41(11): 49-54.